---
figid: PMC7780193__10.1369_0022155420929772-fig3
figtitle: Cell Energy Metabolism and Hyaluronan Synthesis
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC7780193
filename: 10.1369_0022155420929772-fig3.jpg
figlink: /pmc/articles/PMC7780193/figure/fig3-0022155420929772/
number: F3
caption: Schematic representation of HAS2 regulation. Several soluble molecules induce
  activation of transcription factors able to activate HAS2 transcription; HAS2 mRNA
  interacts with several miRNA altering stability and translation; HAS2 protein follows
  the secretory pathway to reach the plasma membrane; HAS2 ubiquitination leads to
  dimerization which represent the active HAS2 on the membrane. In this state, HAS2
  is a very rapidly degraded enzyme; HAS2 O-GlcNAcylation strongly increases half-life
  of the enzyme in the membrane; HAS2 phosphorylation by AMPK blocks HAS2 activity.
  NF-kB and HIF-1α modulate HAS2-AS1 transcription; SIRT1 inhibits HAS2-AS1 that,
  in turn, reduces HAS2 transcription.
papertitle: Cell Energy Metabolism and Hyaluronan Synthesis.
reftext: Ilaria Caon, et al. J Histochem Cytochem. 2021 Jan;69(1):35-47.
year: '2021'
doi: 10.1369/0022155420929772
journal_title: Journal of Histochemistry and Cytochemistry
journal_nlm_ta: J Histochem Cytochem
publisher_name: SAGE Publications
keywords: hyaluronidase | beta glycosidases | hexosamine biosynthetic pathway | UGDH
  | autophagy | ubiquitin | cancer | cardiovascular diseases | metabolic reprogramming
  | HAS2-AS1 | extracellular matrix | proteoglycan | glycosaminoglycan
automl_pathway: 0.9572031
figid_alias: PMC7780193__F3
figtype: Figure
redirect_from: /figures/PMC7780193__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7780193__10.1369_0022155420929772-fig3.html
  '@type': Dataset
  description: Schematic representation of HAS2 regulation. Several soluble molecules
    induce activation of transcription factors able to activate HAS2 transcription;
    HAS2 mRNA interacts with several miRNA altering stability and translation; HAS2
    protein follows the secretory pathway to reach the plasma membrane; HAS2 ubiquitination
    leads to dimerization which represent the active HAS2 on the membrane. In this
    state, HAS2 is a very rapidly degraded enzyme; HAS2 O-GlcNAcylation strongly increases
    half-life of the enzyme in the membrane; HAS2 phosphorylation by AMPK blocks HAS2
    activity. NF-kB and HIF-1α modulate HAS2-AS1 transcription; SIRT1 inhibits HAS2-AS1
    that, in turn, reduces HAS2 transcription.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB1
  - PDGFB
  - BRD2
  - CGA
  - FSHB
  - IGF1
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - TNF
  - IL1B
  - HAS2
  - RER
  - IK
  - NFKB1
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - SP1
  - PSG1
  - DAND5
  - CREB1
  - YY1
  - ZEB1
  - RARA
  - RAB40B
  - RARB
  - RARG
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - SIRT1
---
